Last Updated : October 20, 2005
Details
FilesGeneric Name:
Pegaptanib sodium
Project Status:
Complete
Therapeutic Area:
Macular degeneration, age-related
Manufacturer:
Pfizer Canada Inc.
Brand Name:
Macugen
Project Line:
Reimbursement Review
Project Number:
SR0044-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Macular degeneration, age-related
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
(tentative)
Files
Last Updated : October 20, 2005